Meeting
2018 ASCO Annual Meeting
Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation with cisplatin in locally advanced cervical cancer: A phase II, prospective, randomized, trial.
Authors
Samantha Silva
Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
Samantha Silva , Renata RC Colombo Bonadio , Flavia Gabrielli , Andrea souza Aranha , Maria Luiza Genta , Vanessa Costa Miranda , Daniela Freitas , Elias Abdo Filho , Patricia Alves De Oliveira Ferreira , Karime Kalil , Mariana Scaranti , Maria Del Pilar Estevez-Diz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Cervical Cancer
Clinical Trial Registration Number
NCT01973101
Citation
J Clin Oncol 36, 2018 (suppl; abstr 5523)
DOI
10.1200/JCO.2018.36.15_suppl.5523
Abstract #
5523
Poster Bd #
250
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin with or without CPI-613 as first-line therapy for patients with advanced unresectable biliary tract cancer (BilT-04).
First Author: Vaibhav Sahai
Poster
2019 ASCO Annual Meeting
Defects in DNA repair genes and long-term survival in cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer (MIBC).
First Author: Benjamin Miron
Poster
2016 ASCO Annual Meeting
A Prospective Multicenter Phase II Study of Sorafenib Combined with Cisplatin plus Gemcitabine for the Treatment of Patients with Advanced Renal Collecting Duct Carcinoma (NCT01762150).
First Author: Xinan Sheng
Poster
2013 ASCO Annual Meeting
Neoadjuvant chemotherapy followed by chemoradiation in selected locally advanced squamous cervical cancer.
First Author: Juan Fernando Cueva